Fate Therapeutics Incis A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniathe Company Focuses On Developing Programmed Cellular Immunotherapies For Cancer And Autoimmune Diseasesutilizing A Proprietary Human Induced Pluripotent Stem Cellipscplatformfate Therapeutics Creates Innovative Cell Therapies Designed To Treat Various Hematological Malignancies And Advanced Solid Tumors The Company Specializes In Off The Shelfipsc Derived Cellular Immunotherapiesincluding Engineered Natural Killernkcells And T Cell Product Candidatesthese Therapies Are Designed To Effectively Target Cancer Cells And Elicit Specific Immune Responsesfate Therapeutics Emphasizes The Use Of Clonal Master Ipsc Lineswhich Provide A Renewable Source For Manufacturing High Quality Cell Therapy Products That Can Be Delivered To Multiple Patientsthe Company S Mission Is To Bring First In Class Ipsc Derived Cellular Immunotherapies To Patientsensuring Consistent And Accessible Treatments
